Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
5
×
national blog main
fda
boston
investing
national top stories
biotech ipos
cancer immunotherapy
chronic kidney disease
deals
ipo
medical device
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
ulcerative colitis
480 biomedical
acute myeloid leukemia
ally bridge group
alx oncology
arsenal medical
autoimmune diseases
berkeley lights
big data analytics
blackrock
bob langer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer drugs
cancer vaccine
What
ipo
5
×
raised
5
×
million
new
biotech
company
therapeutics
companies
developing
drug
genetic
life
medicines
momentum
public
raises
science
week
analysis
arrival
bio
biotechs
bring
brings
club
continued
crop
days
debut
develop
diseases
disorders
dyne
dyne’s
employing
exceeded
firms
goldfinch
group
hasn’t
Language
unset
Current search:
ipo
×
raised
×
" life sciences "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M